Publications
61
Citations
329
Est. group size
~16
Recurring co-author estimate
Active years
9
Publishing since 2018
Typically publishes in teams of ~12 · 0% small-team papers (≤3 authors) · across 10 venues
- Abstract B003: Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests
Cancer Research · 2026
- IP49-13 MOLECULAR MARGIN EXTENT IN PROSTATE CANCER VARIES BY ERG FUSION STATUS
The Journal of Urology · 2026
- IP59-20 LESION DISTRIBUTION AND PROGNOSIS OF RENAL CELL CARCINOMA BONE METASTASIS: A NOVEL EVALUATION MODEL BASED ON RANDOM SURVIVAL FORESTS
The Journal of Urology · 2026
- Spatial analysis reveals a novel inflammatory tumor transition state which promotes a macrophage-driven induction of sarcomatoid renal cell carcinoma
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Do tissue-based biomarkers in metastatic clear cell renal cell carcinoma perform better when derived from a metastatic site?
Journal of Clinical Oncology · 2025
- Validation of a 15-gene prognostic signature in metastatic clear cell renal cell carcinoma.
Journal of Clinical Oncology · 2025
- IP16-30 DO TISSUE-BASED BIOMARKERS IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA PERFORM BETTER WHEN DERIVED FROM A METASTATIC SITE COMPARED TO THE PRIMARY?
The Journal of Urology · 2025
- MP28-03 VALIDATION OF A 15-GENE PROGNOSTIC SIGNATURE IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA
The Journal of Urology · 2025
- PD10-05 NARROW RANGE MOLECULAR INFLUENCE OF PROSTATE TUMORS ON SURROUNDING TISSUE REVEALED BY SPATIAL GENOMICS
The Journal of Urology · 2025
- Validation of a 15-Gene Prognostic Signature in Metastatic Clear Cell Renal Cell Carcinoma
JCO Precision Oncology · 2025
- PD51-02 INTEGRATIVE MOLECULAR PROFILING OF RENAL CELL CARCINOMA NATIVE TISSUE AND PATIENT DERIVED ORGANOIDS IDENTIFIES PREDICTIVE MARKERS OF DRUG RESPONSE
The Journal of Urology · 2024
- Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype
Cancers · 2023
- Role of Adenosine Deaminase in Prostate Cancer Progression
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Abstract 232: Fully automated comprehensive genomic profiling for detection of cancer variants, gene fusions, and complex oncology endpoints
Cancer Research · 2023
- Integrative multi-region molecular profiling of primary prostate cancer with synchronous lymph node metastasis to characterize the biologically dominant clone
Research Square · 2023
- The Journal of Urology×17
- Journal of Clinical Oncology×11
- JCO Precision Oncology×3
- PMC×3
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Amy Kasputis
Medicine · University of Michigan
- Trinh Pham
Medicine · University of Michigan
- Clinton D. Bahler
Medicine · Indiana University
- Daniel Triner
Medicine · University of Michigan
- Ulka N. Vaishampayan
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile